ArticlePDF Available

Abstract and Figures

Chemokine Receptor type 4 (CXCR4) is the increasing interest as a drug target, which is involved in many disease states including more than 23 types of cancer and several immunodeficiency disorders. On the other hand, the chemical constituents of medicinal plant are helpful in the discovery of therapeutic agents. Therefore the main aim of the study was to analyze the inhibitory activity of linoleic acid against CXCR4. Previous studies the natural compound of linoleic acid was isolated and identified from ethanolic extract of Cayratia trifolia. The molecular docking analysis was carried out to find the CXCR4 inhibitory activity of the isolated compound. Results, the isolated compound of linoleic acid possess comparable good Glide score and Glide energy when compared with FDA approved drug. Based on the results, it can be concluded that, the isolated compound of linoleic acid may act as novel inhibitor aginst CXCR4 and further it can be lead to development of therapeutic agent for variety of cancers and other disorders. © 2015, International Journal of Pharmacognosy and Phytochemical Research. All Rights Reserved.
Content may be subject to copyright.
Available online on www.ijppr.com
International Journal of Pharmacognosy and Phytochemical Research 2015; 7(4); 781-784
ISSN: 0975-4873
Research Article
*Author for Correspondence
CXCR4 Inhibitory Activity Analysis of Linoleic Acid Isolated from
Ethanolic Extract of Cayratia trifolia (L.): An Molecular Docking
Simulation
Chella Perumal P1,Pradeep Kumar Reddy C2,Pratibha P1, Sowmya S1, Priyanga S3, Devaki
K3, Poornima K3, Ramkumar S3, Gopalakrishnan VK1*
1Cancer Biology and Medicinal Chemistry Unit, Department of Biochemistry & Bioinformatics,
Karpagam University, Coimbatore, Tamil Nadu, India-641 021.
2Laboratory of Conformational Diseases, Biological Research Centre, Hungarian Academy of Sciences,
Szeged-6726, Hungary.
3Department of Biochemistry, Karpagam University, Coimbatore, Tamil Nadu, India-641 021.
Available Online: 21st July, 2015
ABSTRACT
Chemokine Receptor type 4 (CXCR4) is the increasing interest as a drug target, which is involved in many disease states
including more than 23 types of cancer and several immunodeficiency disorders. On the other hand, the chemical
constituents of medicinal plant are helpful in the discovery of therapeutic agents. Therefore the main aim of the study
was to analyze the inhibitory activity of linoleic acid against CXCR4. Previous studies the natural compound of linoleic
acid was isolated and identified from ethanolic extract of Cayratia trifolia. The molecular docking analysis was carried
out to find the CXCR4 inhibitory activity of the isolated compound. Results, the isolated compound of linoleic acid
possess comparable good Glide score and Glide energy when compared with FDA approved drug. Based on the results, it
can be concluded that, the isolated compound of linoleic acid may act as novel inhibitor aginst CXCR4 and further it can
be lead to development of therapeutic agent for variety of cancers and other disorders.
Keywords: Cayratia trifolia (L.); Linoleic acid; CXCR4; Molecular docking analysis.
INTRODUCTION
The chemokine gradients are playing significant role
movement of cells in a variety of normal and pathologic
processes. Cancers have a complex chemokine network
that may influence the leucocyte infiltrate and
angiogenesis1. Malignant cells can also state the
chemokine receptors and respond to chemokine gradients
and this may be associated with the development and
spread of cancer. Different cancers express different CC
and CXC chemokine receptors and the corresponding
ligands are sometimes expressed at sites of tumour
spread2,3. There is one chemokine receptor, however,
Chemokine Receptor type 4 (CXCR4) is a G-protein-
coupled membrane receptor which is present in various
cell types. It is increasing interest as a drug target and it
can be involved in many disease states including more
than 23 types of cancer and several immunodeficiency
disorders4. CXCR4 has been shown to play a critical role
in (breast) cancer progression and metastatic spread. It
has been reported that 69% of ductal carcinoma in situ
(DCIS) lesions are CXCR4-positive. Over-expression of
CXCR4 has also been suggested to be of value for
imaging applications5. As a number of reviews have
recently been published highlighting CXCR4 as a target
in HIV and its role in cancer metastasis6.
Consideration of the bioactive compounds from the
medicinal plant is helpful to discovery of therapeutic
agents as well as new sources of economic materials like
oil and gums7. Secondary metabolites from medicinal
plants have demonstrated to be an excellent reservoir of
new medical compounds8. Numbers of bioactive
compounds are present in medicinal plants which are
widely used against variety of diseases9.Cayratia trifolia
(L.) is the medicinal plant belongs to the family of
Vitaceae, commonly known as Fox grape in English is
native to India, Asia and Australia. It is a perennial
climber having trifoliated leaves with (2-3 cm), long
petioles and ovate to oblong-ovate leaflets. Flowers are
small greenish white brown in color. Fruits are fleshy,
juicy, dark purple or black, nearly spherical, about 1 cm
in diameter10. The whole plant is used as anti diuretic, in
tumors, neuralgia and splenopathy. It has been reported to
contain huge amount of bioactive compounds such as
yellow waxy oil, steroids, terpenoids, flavonoids and
tannins11. The bark extract has been reported to have
antiviral, antibacterial, antiprotozoal, hypoglycemic,
anticancer and diuretic activities in animal models12.
Therefore, the aim of the present research work is to
analyze the inhibitory activity of linoleic acid (Isolated
Chella Perumal P et al.. / CXCR4 Inhibitory Activity…
IJPPR, Volume 7, Issue 4, August 2015- September 2015 Page 782
Table 1: GlideScores and GlidEnergies of various
ligands with CXCR4 (the natural compounds are
identified from ethanolic extract of Cayratia trifolia (L.)
and carboplatin is a FDA approved drug) complexes are
given as calculated from the molecular docking studies.
S
.
N
o
Compounds
Glide Score
Glide
Energy
1
Linoleic acid
-4.585
-32.114
2
Carboplatin (FDA
drug)
-6.024
-25.039
Table 2: ADME properties of selected compounds as
predicted by using QikProp module of Schrodinger suite
are listed.
S.
N
o
Molecula
r Weight
(g/mol)
H-
Bond
dono
r
H-Bond
accepto
r
Log
P
O/W
1
280.44
1
2
5.84
2
144.12
0
2
1.35
from ethanolic extract of Cayratia trifolia) against
CXCR4 computational molecular analysis.
MATERIALS AND METHODS
Computational molecular analysis
Ligand selection preparation
Based on the previous studies, the isolated compound of
linoleic acid13 and FDA approved drug of Carboplatin
(standard drug for comparison) were selected and
prepared using the LigPrep 2.4 module from Schrodinger
suit14 for molecular docking analysis. The structure of
each ligands were optimized by means of the OPLS 2005
force field using a default setting.
Preparation of protein structure
The high resolution crystal structure of (3D structure)
CXCR4 was retrieved from the Protein Data Bank (PDB
ID: 3OE6) and it was prepared by protein preparation
wizards (standard methods) that are available in grid-
based ligand docking with energetics15. Protein was
optimized using sample water orientation and minimized
by using RMSD 0.30 Å and OPLS (2005) force field.
Active site prediction
The binding pockets (active site) and functional residues
in CXCR4 were identified and characterized by Site- Map
5.5 module from Schrodinger suit16. SiteMap calculation
begins with an initial search step that identifies or
characterizes- through the use of grid points- one or more
regions on the protein surface that may be suitable for
binding ligands to the receptor. Contour maps were then
generated, hydrogen binding possibilities, hydrophilic
maps, produced hydrophobic are may guide the protein-
ligand docking analysis17.
Molecular docking analysis
The docking analysis was performed by using the
standard precision (SP) which is Standard mode of Glide
5.6 (Gridbased Ligand Docking with Energetic) module
from Schrodinger suit18. The selected natural compound
of linoleic acid and FDA approved drug were docked in
to the binding site of CXCR4 using Glide modiule. The
scaling Vander Waals radii were 1.0 in the receptor grid
generation. Grid was prepared with the bounding box set
on 20Aº. The co-ordinates of this enclosing box with the
help of the active site residues to be set default. The force
field is using for the docking protocol is OPLS_2005. The
docked lowest-energy complexes were found in the
majority of similar docking conformations19.
ADME properties prediction
The CXCR4 ligands of linoleic acid and FDA drug were
checked for their ADME properties using QikProp 2.3
module20. It helps to analyze the pharmacokinetics and
pharmacodynamics of the ligands by accessing the drug
like properties. The significant ADME properties such as
Molecular weight (MW), H-Bond donor, H Bond
acceptor and log P (O/W) were predicted.
RESULTS AND DISCUSSION
In India, great number of plant species had been screened
for their pharmacological properties but still vast wealth
of rare species is unexplored21. Medicinal plants are at
interest to the field of novel drug development, as most of
the drug industries depend on medicinal plants for the
production of novel bioactive compounds22. The isolated
bioactive compound of linoleic acid posses many
biological activities such as anti-inflammatory, anti-
microbial and anti-diabetic activities23. The best active
site (binding pocket/site) was preferred based on the site
score and hydrophobic/hydrophilic areas, which holds
better binding cavity24. The binding site residues of
CXCR4 were predicted and it may involve in the binding
of substrate and small molecule. Thus, all these residues
were confirmed as CXCR4 active site residues and picked
to generate grid in the centroid of these residues for
molecular docking approach.
Normally the molecular docking study is used to predict
the binding orientation of small molecule drug candidate
to their protein targets in order to predict the affinity and
activity of the small molecule. In the docking results of
linoleic acid and FDA approved drug of Carboplatin were
complexes with CXCR4 protein shown in Table 1.
Among that the natural compound of linoleic acid has
good binding affinity when compared with FDA drug.
In the CXCR4-linoleic acid complex (Figure 1) possess
Glide score of -4.585 and Glide energy of -32.114
kcal/mol, when compared with CXCR4/carboplatin
complex which has Glide score of -6.02 and Glide energy
of -25.03 kcal/mol. The linoleic acid strongly binds in
hydrophobic region of CXCR4 at LYS239 residue. In the
same way CXCR4/carboplatin complex also possess good
affinity (Figure 2).
Chemokines and chemokine receptors regulate the
physiological movement of immune cells in the body25.
Among the family of chemokine and chemokine
receptors mediating tumor cell invasion and metastasis,
CXCL12/CXCR4 has gained a central role in different
types of tumors in mediating tumor growth, angiogenesis
Chella Perumal P et al.. / CXCR4 Inhibitory Activity…
IJPPR, Volume 7, Issue 4, August 2015- September 2015 Page 783
and metastasis. In prostate cancer cells, CXCL12 and
CXCR4 play a key role in invasion and metastasis,
leading to development and expansion of osseous
metastasis26,27. Thus, targeting CXCR4 can have dual
effects on inhibiting primary tumor growth and metastasis
or mono effect on inhibiting either tumor growth or
metastasis28. In the molecular docking analysis the
highest negative value of glide score and glide energy
indicated that, these complexes may have good affinity29
and this compound may act as good CXCR4 inhibitor.
The ADME properties prediction of linoleic acid was
under acceptable range. The limitations of ADME
properties are: not more than 5 hydrogen bond donors,
not more than 10 hydrogen bond acceptor, molecular
mass less than 500 daltons, an octanol- water partition
coefficient log P not greater than 5 (Table 2).
CONCLUSION
In the present, the isolated and identified natural
compound of linoleic acid was analyzed for their
inhibitory activity against CXCR4 using molecular
docking analysis and the drug like properties also were
predicted. In the results, linoleic acid was strongly binds
with CXCR4 when compared with FDA drug. The
ADME properties of these compounds were acceptable
range. Therefore, based on the results, it can be
concluded that, the isolated bioactive compound of
linoleic acid may work as novel inhibitor against CXCR4
and it may leads to development of drug agents for
variety of cancers and other disorders.
CONFLICT OF INTEREST STATEMENT
The authors declare that there is no conflict of interests
regarding the publication of this paper.
ACKNOWLEDGEMENT
The authors are thankful to our Chancellor, Chief
Executive Officer, Vice-Chancellor and Registrar of
Karpagam University for providing facilities and
encouragement. Our grateful thanks to Indian Council of
Medical Research (ICMR), New Delhi for providing the
financial support (File No: BIC/11(19)/2013) to this
research work. We extend our deepest thanks to Dr. D.
Jeya Sundra Sharmila, Karunya University for providing
us an opportunity to use Schrodinger Suite (in silico
analysis).
REFERENCES
1. Balkwill F. Chemokine biology in cancer. Sem
Immunol 2003; 15:49–55.
Figure 1: Docking complex of CXCR4 with A) Linoleic acid and B) FDA approved drug generated by using Glide-SP
module of Schrodinger suite are shown in this figure. The proteins, ligands and binding pockets are represented in
ribbon, sticks and surface models, respectively.
Figure 2: Residues of the CXCR4 that are within 4 Å proximities to A) Linoleic acid and B) FDA approved drug are
illustrated in 2D graphics. Dotted arrow lines denote ‘Hydrogen bonds’ between the corresponding atoms.
Chella Perumal P et al.. / CXCR4 Inhibitory Activity…
IJPPR, Volume 7, Issue 4, August 2015- September 2015 Page 784
2. Muller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W,
Wagner SN, Barrera JL, Mohar A, Verástegui E,
Zlotnik A. Involvement of chemokine receptors in
breast cancer metastasis. Nature 2001; 410:50–56.
3. Murphy PM. Chemokines and molecular basis of
cancer metastasis. N Engl J Med 2001; 354:833–835.
4. Balkwill F. The significance of cancer cell expression
of the chemokine receptor CXCR4. Semin Cancer
Biol 2004; 14:171–179.
5. Kuil J, Yuan H, Buckle T, Oishi S, Fujii N, Josephson
L, Van Leeuwen FWB. Synthesis and in vitro
evaluation of a bimodal CXCR4 antagonistic peptide.
Bioconjug Chem 2011; 22:859–864.
6. Busillo JM, Benovic JL. Regulation of CXCR4
signaling. Biochim Biophys Acta 2007; 1768:952–
963.
7. Priyanga S, Hemmalakshmi S, Devaki K.
Comparative Chromatographic Fingerprint Profiles of
Ethanolic Extract of Macrotyloma uniflorum L.
Leaves and Stem. Int J Pharmaceut Cli Res 2014;
6:288-299.
8. Poornima K, Perumal PC, Gopalakrishnan VK.
Protective effect of ethanolic extract of
Tabernaemontana divaricata (L.) R. Br. against DEN
and Fe NTA induced liver necrosis in Wistar Albino
rats. Biomed Res Int 2014; 2014:1-9.
9. Priyanga S, Hemmalakshmi S, Devaki K.
Comparative phytochemical investigation of leaf,
stem, flower and seed extracts of Macrotyloma
uniflorum L. Indo Am J Pharm Res 2014; 4:5415-
5420.
10.Perumal PC, Sophia D, Raj CA, Ragavendran P,
Starlin T, Gopalakrishnan VK. In vitro antioxidant
activities and HPTLC analysis of ethanolic extract of
Cayratia trifolia (L.). Asian Pac J Trop Dis 2012;
2:S952-S956.
11.Sowmya S, Perumal PC, Anusooriya P, Vidya B,
Pratibha P, Gopalakrishnan VK. In vitro antioxidant
activity, in vivo skin irritation studies and HPTLC
analysis of Cayratia trifolia (L.) Domin. Int J Tox
Pharm Res 2015; 7:1-9.
12.Kumar D, Gupta J, Kumar S, Arya R, Kumar T, Gupta
A. Pharmacognostic evaluation of Cayratia trifolia
(Linn.) leaf. Asian Pac J Trop Biomed 2012; 5:6-10.
13.Perumal PC, Sowmya S, Pratibha P, Vidya B,
Anusooriya P, Starlin T, Ravi S, Gopalakrishnan VK.
Isolation, structural characterization and in silico
drug-like properties prediction of bioactive compound
from ethanolic extract of Cayratia trifolia (L.).
Pharmacog Res 2015; 7:121-125.
14.LigPrep version 2.4. Schrödinger LLC, New York,
2012.
15.Protein Preparation Wizard, Schrödinger LLC, New
York, 2012.
16.SiteMap 5.5, Schrodinger, LLC, NewYork, 2012.
17.Tripathi SK, Singh SK, Singh P, Chellaperumal P,
Reddy KK, Selvaraj C. Exploring the selectivity of a
ligand complex with CDK2/CDK1: a molecular
dynamics simulation approach. J Mol Recognit 2012;
25:504-512.
18.Glide version 5.6. Schrödinger, LLC, New York,
2012.
19.Pratibha P, Sophia D, Perumal PC, Gopalakrishnan
VK. In-silico docking analysis of Emilia sonchifolia
(L.) DC. gas chromatography-mass spectroscopy
derived terpenoid compounds against pancreatic
cancer targets (AKT and BRCA2). World J Pharm
Pharm Sci 2014; 3:1844-1855.
20.QikProp, Version 2.3, Schrodinger, LLC, New York,
2012.
21.Priyanga S, Mary MRF, Hemmalakshmi S, Devaki K.
Anti hyperlipidemic effect of aqueous extract of Aegle
marmelos and Camellia sinensis in oil fed
hyperlipidemic rats. Int J Pharm Pharm Sci 2014;
6:338-341.
22.Starlin T, Ragavendran P, Raj CA, Perumal PC,
Gopalakrishnan VK. Element and functional group
analysis of Ichnocarpus frutescens R. Br.
(Apocynaceae). Int J Pharm Pharm Sci 2012; 4:343-
345.
23.Perumal PC, Sowmya S, Pratibha P, Vidya B,
Anusooriya P, Starlin T, Vasanth R, Jeya sundra
sharmila D, Gopalakrishnan VK. Identification of
novel PPARγ agonist from GC-MS analysis of
ethanolic extract of Cayratia trifolia (L.): a
computational molecular simulation studies. J App
Pharm Sci 2014; 4:006-011.
24.Srinivasan P, Perumal PC, Sudha A. Discovery of
Novel Inhibitors for Nek6 Protein through Homology
Model Assisted Structure Based Virtual Screening and
Molecular Docking Approaches. Scientific World J
2014; 2014:1-9.
25.Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov
E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison
S, Rosser CJ. Effects of CXCR4 antagonist CTCE-
9908 on prostate tumor growth. Prostate 2009;
69:1460–1469.
26.Sun YX, Wang J, Shelburne CE, Lopatin DE,
Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS.
Expression of CXCR4 and CXCL12 (SDF-1) in
human prostate cancers (PCa) in vivo. J Cell Biochem
2003; 89:462–473.
27.Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J,
Taichman RS, Pienta KJ, Wang J. CXCL12 / CXCR4
/ CXCR7 chemokine axis and cancer progression.
Cancer Metastasis Rev 2011; 29:709–722.
28.Wong D, Kandagatla P, Korz W, Chinni SR.
Targeting CXCR4 with CTCE-9908 inhibits prostate
tumor metastasis. BMC Urology 2014; 14:1-7.
29.Walker SD, Eldowney SM. Molecular docking: A
potential tool to aid ecotoxicity testing in
environmental risk assessment of pharmaceuticals.
Chemosphere 2013; 93:2568–2577.
... ere are various chemical compounds present in plants, these compounds are capable of treating certain diseases, and few compounds also possess pharmacological properties such as antioxidant, anticancer, antidiabetic, and anti-inflammatory [12,29]. To identify and isolate, the phytochemicals through chromatographic and spectrometric techniques are employed, and these techniques provide a piece of efficient information regarding the composition of the phytochemicals of plants, especially medicinal plants; it is also extended even to find out the quality and quantity of the compounds extracted from the medicinal plants [30]. ...
Article
Full-text available
Bioactive compound (5E,7E)-4,5,6 trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate (compound 2) was isolated from Euclea crispa (E. crispa) by the chromatographic methods. Further, the compound was confirmed by spectroscopic techniques such as ultraviolet-visible (UV/Vis) spectrometer, Fourier transform infrared (FTIR) spectrometer, and 1H and 13C nuclear magnetic resonance (NMR). Compound 2 exhibited a significant antioxidant activity with IC50 values. It restrained the auxesis of HO-8910 cells in a shot-dependent mode. CXCR4, HER2, and Akt proteins involved in cell proliferation and metastasis were found to be significantly reduced ( p < 0.05 ). The protein that is responsible for the death of cells (Bcl-2 and Bcl-xL) was reduced ( p < 0.05 ), while the protein expression of p53 and caspase-9 was increased ( p < 0.05 ) in compound 2-treated HO-8910 cells. The results of molecular docking analysis showed the binding affinity with CXCR4 and HER2. Thus, compound 2 can serve as a promising chemotherapeutic agent for the intervention of ovarian cancer. The findings of this study conclude that compound 2 from E. crispa might work as a potential antioxidative and chemotherapeutic agent. The in vivo studies and attempts will pave way for this compound to be an effective drug hereafter.
... Optical rotation was determined with a Perkin-Elmer olarimeter (model 341). NMR spectra on solutions in deuterated chloroform (CDCl 3 ) were recorded on a Bruker DRX-500 NMR Spectrometer at 500 MHz (1H) and 125 MHz (13C); the signals of the deuterated solvent were taken as a reference (Perumal et al., 2015a). ...
Article
Edited by AR Ndhlala The purpose of the present study attempt to investigate the antioxidant and antimicrobial activities of isolated bioactive compound from ethanolic extract of Euclea crispa (E. crispa) leaves. Column chromatography method was used to isolate the bioactive compound from the plant leaves followed by UV-Spectroscopy. FT-IR, 1 H and 13 C NMR analyses were used to identify the structure of the isolated compound. Subsequently, the antioxidant activity was demonstrated by 2, 2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging assay, reducing power assay, ferric reducing antioxidant power (FRAP) assay, hydroxyl scavenging assay and nitric oxide scavenging assay while disc-diffusion assay was used to analyze the antimicrobial activity. The NMR and other spectral data confirmed that the isolated compound was (6E, 10E)-2, 6, 24-trimethylpentacosa-2, 6, 10-triene (com-pound-1). The DPPH radical scavenging (116.1 ± 0.9 μg/ml), hydroxyl scavenging (118.9 ± 1.0 μg/ml) and nitric oxide scavenging (124.3 ± 0.2 μg/ml) showed the significant half maximal inhibitory concentration (IC 50) values on compound-1 suggesting good antioxidative potential. Additionally, it exhibited considerable activity in reducing power and FRAP (the maximum absorption of 0.41 ± 0.02 and 0.54 ± 0.02 at 500 μg/ml, respectively) when compared with standard drug. Furthermore, compound-1 showed maximum antimicrobial activity with inhibition zone against the tested microorganism of Staphylococcus aureus, Streptococcus aureus, Escherichia coli, Klebsi-ella pneumonia, Aspergillus niger and Aspergillus terreus. Conclusively, the isolated bioactive compound-1 from E. crispa leaves could be a new source of natural antioxidative and antimicrobial agents with potential value.
Article
Full-text available
Sida acuta is one of the Indian medicinal plant which belongs to the family Malvaceae. The whole plant is reported to have many biological activities such as abortifacient, anthelmintic, antiemetic, demulcent, diuretic, aphrodisiac, stomachic, diaphoretic, antipyretic and wound healing properties. Therefore main aim of the present study is to evaluate the phytochemical constituents and the free radical scavenging properties of the chloroform extract of sida acuta. Screening of phytochemical constituents and free radical scavenging potential were analyzed by DPPH radical scavenging assay, Nitric oxide radical scavenging assay, Hydroxyl radical scavenging assay, Reducing power assay and FRAP assay. The preliminary phytochemical screening has shown the presence of Steroids, flavonoids, tannins and Glycosides. The chloroform extract of Sida acuta hold restrained free radical scavenging activities. Based on the results this study can be concluded that, sida acuta has rich free radical scavenging activities, may be which the presence these secondary metabolites in it. In future by isolating and identifying these compounds, if may be used to treat various diseases. © 2016, International Journal of Pharmacognosy and Phytochemical Research. All rights reserved.
Article
Full-text available
Macrotyloma uniflorum (L.) is belonging to the family fabaceae. Various parts of this plant used to cure ailments like heart conditions, asthma, bronchitis, leucoderma and in the treatment of kidney stones etc. The present study was focused to evaluate the HPTLC fingerprinting analysis of M.uniflorum leaf and stem. HPTLC fingerprinting profiles was done by using Hamilton syringe and CAMAG LINOMAT 5 instrument. HPTLC fingerprinting profile confirms the presence of alkaloids, glycosides, flavanoids, phenols, steroids and terpenoids. Among all the solvents in the phytochemical screening the ethanolic extract shows most of the secondary metabolites such as alkaloids, flavanoids, cardio glycosides, phenols, tannins, terpenoids, steroids etc. From the above results the ethanolic extract of M. uniflorum leaf shows better activity. So, that it can be used as therapeutic agent to treat various diseases due to the presence of enormous secondary metabolites. INTRODUCTION Medicinal plants are very ancient and traditionally used for thousands of years and having rich sources of bioactive compounds and thus serve as a vital raw material for drug production and have become a goal for the search of new drugs 1. They can be used directly or in extracted forms for the administration of various ailments due to the presence of various phytochemical constituents 2,3. Their therapeutic values to human health have been reported in the different systems of medicine. Hence the modern methods describing the identification and quantification of active constituents in the plant material may be useful for proper standardization of herbals and its formulation 4
Article
Full-text available
Phytochemicals are secondary metabolites produced by medicinal plants and reported to have therapeutic values. The major aim of the present study was to investigate the phytochemical screening of various extracts of Macrotyloma uniflorum L. leaves, stem, flower and seed. Petroleum ether, chloroform, ethyl acetate, ethanol and water extracts were prepared and subjected to phytochemical screening in which the secondary metabolites were confirmed based on tests of colouration and precipitation. The leaves and stem have shown the presence of all the bioactive constituents like alkaloids, flavonoids, saponins, terpenoids, tannins etc. Flowers and seed show limited amount of phytoconstituents when compared to that of leaves and stem. Among the various extracts used, the ethanolic extract of Macrotyloma uniflorum leaves and stem were found to have accountsable number of phytoconstituents.
Article
Full-text available
Objective: Hyperlipidemia is a serious health problem and greatest cause of death all over the world, and if not treated, it is responsible for many complications affecting various organs in the body. The present research was carried out to find the inhibitory activity of HMGCoA reductase, ACAT (Acyl coenzymeA cholesterol acyl transferase) and antihyperlipidemic effect of Aegle marmelos and Camellia sinensis in oil fed rats. Methods: The aqueous leaf extract of Aegle marmelos and Camellia sinensis was administered to the control and experimental rats for 21 days. After the experimental period the animals were sacrificed and the serum, tissue samples were used for its enzyme inhibitory activity and lipid metabolism analysis by using standard protocol. Results: HMGCoA reductase is a key enzyme which continued the rate limiting step of cholesterol biosynthesis. Treatment with herbal drugs like Aegle marmelos and Camellia sinensis showed a significant decrease in the ACAT, HMGCoA reductase levels and significant increase in high density lipoprotein level. After treatment with Aegle marmelos and Camellia sinensis the histopathology results of liver proves the promising effect againt hyperlipidemia. Conclusion: It is concluded that the aqueous leaf extract of Aegle marmelos and Camellia sinensis can be applied clinically for the management of hyperlipidemia and cardiovascular complications.
Article
Full-text available
Nek6 is a member of the NIMA (never in mitosis, gene A)-related serine/threonine kinase family that plays an important role in the initiation of mitotic cell cycle progression. This work is an attempt to emphasize the structural and functional relationship of Nek6 protein based on homology modeling and binding pocket analysis. The three-dimensional structure of Nek6 was constructed by molecular modeling studies and the best model was further assessed by PROCHECK, ProSA, and ERRAT plot in order to analyze the quality and consistency of generated model. The overall quality of computed model showed 87.4% amino acid residues under the favored region. A 3 ns molecular dynamics simulation confirmed that the structure was reliable and stable. Two lead compounds (Binding database ID: 15666, 18602) were retrieved through structure-based virtual screening and induced fit docking approaches as novel Nek6 inhibitors. Hence, we concluded that the potential compounds may act as new leads for Nek6 inhibitors designing.
Article
Full-text available
Medicinal plants are in all way having its own immense importance in current era. Many plants synthesize substances that are useful to the maintenance of health in humans and animals. All plants produce chemical compounds as a part of their normal metabolic activities. These metabolic activities can be measured using HPLC, FTIR, and SEM-EDX etc. The aim of the present study is to identify the functional group and to analyze the trace elements in Ichnocarpus frutescens. The quantification of chemical constituents in plant material was carried out by using standard procedures. The findings indicated the presence of amino acids, amides, amines, carboxylic acid, carbonyl compounds, organic hydrocarbons, halogens and the SEM-EDX showed the presence of calcium, magnesium, silicon, chloride, potassium, and carbon in ethanolic extract of Ichnocarpus frutescens. However, the current study gives a new, alternative, easy and reliable method for the standardization of the crude extract derived from various medicinal plants.
Article
Full-text available
This study is an attempt to evaluate the hepatoprotective activity of Tabernaemontana divaricata against DEN and Fe NTA induced liver necrosis in rats. Ethanolic extract of the whole plant of Tabernaemontana divaricata at doses of 200 and 400mg/kg bodyweight and 5-fluorouracil (standard drug) was orally administered to male Wistar Albino rats once daily for 24 weeks, simultaneously treated with the carcinogen DEN and Fe NTA. In simultaneously treated animals, the plant extract significantly decreased the levels of uric acid, bilirubin, AST, ALT, and ALP in serum and increased the levels of liver marker enzymes in liver. Treatment with the extracts resulted in a significant increase in the levels of antioxidants accompanied by a marked reduction in the levels of malondialdehyde when compared toDENand Fe NTAtreated group. When compared with 200mg/kg bw rats, 400mg/kg bwrats and 5-fluorouracil treated rats showed better results in all the parameters. The histopathological studies confirmed the protective effects of extract against DEN and Fe NTA induced liver necrosis. Thus, it could be concluded that the use of Tabernaemontana divaricata extract in the treatment of carcinogen induced hepatic necrosis.
Article
Full-text available
Oxidative stress and inflammation are constant features of many chronic diseases and complications and it have been linked to carcinogenesis. Antioxidants from natural sources play a paramount role in serving endogenous antioxidants to neutralize oxidative stress. Thus, the aim of this study was to evaluate enzymatic and non-enzymatic antioxidant capacity and anti-skin irritation activity of Cayratia trifolia against perchloroethylene (PCE) induced wistar albino rats. The total alkaloid, flavonoid, phenol and tannin and antioxidant assays like, catalase, peroxidase, superoxide dismutase, vitamin C were estimated. Skin irritation was induced through wiping PCE in knee skin of experimental rats. After 30 days the rats were sacrificed and histopathological studies were done. Enzymatic and non-enzymatic antioxidant assays revealed that, the ethanolic extract of Cayratia trifolia posseses comparable antioxidant activity with standard drug. The HPTLC analysis shown that, tannin and phenol compounds present in this extract. The histopathological results, when compared with control, PCE induced groups showed mild inflammation whereas ethanolic extract of Cayratia trifolia treated groups showed compact inflammation. Based on the results, it can be concluded that, ethanolic extract of Cayratia trifolia perhaps a natural source of antioxidants. In future, it may be potential natural resources for pharmacology of functional foods. INTRODUCTION Plants are the precious, incredible and traditional sources for the curability of various diseases in the form of medicines 1. They are the main source of drugs that are being used from the ancient times as an herbal remedies for the health care, prevention and cure of various diseases and ailments 2. They are rich sources of bioactive compounds and they serve as an important raw material for drug production and have become a target for the search of new drugs 3
Article
Full-text available
Peroxisome Proliferator-Activated Receptor gamma (PPARγ) is a nuclear receptor family transcription factor that is expressed in several types of cancers. Antiproliferative and proapoptotic actions of PPARγ agonists suggesting that, it could be a promising therapeutic target for the treatment of variety of cancers. Therefore, the main aim of this study is attempt to identify the novel PPARγ agonist from presence of bioactive compounds in ethanolic extract of Cayratia trifolia using GC-MS analysis and Computational molecular simulation studies. The GC-MS analysis revealed that the ethanolic extract of Cayratia trifolia (L.) (whole plant) consist of 20 bioactive compounds which embrace many biological activities against variety of diseases. Molecular docking studies (Glide 5.5 from Schrödinger suite) exposed that, out of 20 bioactive compounds, Cyclopentadecane, 9- Borabicyclo [3.3.1]nonane, 9-(2-propen-1-yloxy)-.1, 4,8,12,16-Tetramethylheptadecan-4- olide, Oxirane and Vitamin E shows the better glide score. ADME properties (QikProp 2.3 from Schrödinger suite) of these bioactive compounds were under the acceptable range. Based on the result it can be concluded that, these bioactive compounds may act as a good agonist for PPARγ. In future it may focus on current discoveries in PPARγ activation and possible anticancer therapeutic option.
Article
Full-text available
Natural products have continually played an important role in drug discovery because it serves as active principles in drugs as well as templates for synthesis of new drugs. Cayratia trifolia (L.) is a medicinal plant, which has been reported to have antiviral, antibacterial, antiprotozoal, hypoglycemic, anticancer and diuretic activities. Therefore, the objective of this study is to isolate and identify the natural compound from the ethanolic extract of Cayratia trifolia (L.) and to predict the Absorption, Distribution, Metabolism and Excretion (ADME) properties of isolated natural compound. Column chromatography and thin layer chromatography were used to isolate the natural compound and Fourier-transform infrared (FTIR) spectroscopy was used to predict the functional groups present in the isolated natural compound. The structural characterization studies were functionally carried out using (1)H, (13)C, two-dimensional nuclear magnetic resonance (NMR) and mass spectrometry methods. FTIR showed that, the groups of OH, C-H, C = C may be present in the isolated natural compound. (1)H, (13)C, two-dimensional NMR and mass spectrometry data suggests that the isolated natural compound probably like linoleic acid. In silico ADME properties, prediction of the compound was under acceptable range. Based on the results, it can be concluded that, the isolated natural compound of linoleic acid that has been exhibited good medicinal properties.